These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 28161581

  • 1. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62.
    Majima R, Shindoh K, Yamaguchi T, Inoue N.
    Antiviral Res; 2017 Apr; 140():142-150. PubMed ID: 28161581
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Functional Characterization of the Serine-Rich Tract of Varicella-Zoster Virus IE62.
    Kim SK, Shakya AK, Kim S, O'Callaghan DJ.
    J Virol; 2016 Jan 15; 90(2):959-71. PubMed ID: 26537679
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.
    Perera LP, Mosca JD, Ruyechan WT, Hayward GS, Straus SE, Hay J.
    J Virol; 1993 Aug 15; 67(8):4474-83. PubMed ID: 8392592
    [Abstract] [Full Text] [Related]

  • 6. Varicella-zoster virus IE62 protein utilizes the human mediator complex in promoter activation.
    Yang M, Hay J, Ruyechan WT.
    J Virol; 2008 Dec 15; 82(24):12154-63. PubMed ID: 18842726
    [Abstract] [Full Text] [Related]

  • 7. Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.
    Shakya AK, O'Callaghan DJ, Kim SK.
    J Virol; 2019 Jun 15; 93(12):. PubMed ID: 30918075
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
    Ahn JH, Hayward GS.
    Virology; 2000 Aug 15; 274(1):39-55. PubMed ID: 10936087
    [Abstract] [Full Text] [Related]

  • 12. Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells.
    Cohrs RJ, Wischer J, Essman C, Gilden DH.
    J Virol; 2002 Jul 15; 76(14):7228-38. PubMed ID: 12072522
    [Abstract] [Full Text] [Related]

  • 13. Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression.
    Jenkins DE, Martens CL, Mocarski ES.
    J Gen Virol; 1994 Sep 15; 75 ( Pt 9)():2337-48. PubMed ID: 8077932
    [Abstract] [Full Text] [Related]

  • 14. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME, Cudahy MM, Brideau RJ, Homa FL, Hopkins TA, Knechtel ML, Oien NL, Pitts TW, Poorman RA, Wathen MW, Wieber JL.
    J Med Chem; 2005 Sep 08; 48(18):5794-804. PubMed ID: 16134946
    [Abstract] [Full Text] [Related]

  • 15. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.
    Muganda P, Carrasco R, Qian Q.
    Cell Mol Biol (Noisy-le-grand); 1998 Mar 08; 44(2):321-31. PubMed ID: 9593583
    [Abstract] [Full Text] [Related]

  • 16. Varicella-zoster virus gene 21: transcriptional start site and promoter region.
    Cohrs RJ, Barbour M, Gilden DH.
    J Virol; 1998 Jan 08; 72(1):42-7. PubMed ID: 9420198
    [Abstract] [Full Text] [Related]

  • 17. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
    Lowry PW, Koropchak CM, Choi CY, Mocarski ES, Kern ER, Kinchington PR, Arvin AM.
    Antiviral Res; 1997 Feb 08; 33(3):187-200. PubMed ID: 9037375
    [Abstract] [Full Text] [Related]

  • 18. Analysis of IE62 mutations found in Varicella-Zoster virus vaccine strains for transactivation activity.
    Ko H, Lee GM, Shin OS, Song MJ, Lee CH, Kim YE, Ahn JH.
    J Microbiol; 2018 Jun 08; 56(6):441-448. PubMed ID: 29858833
    [Abstract] [Full Text] [Related]

  • 19. The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.
    Luganini A, Mercorelli B, Messa L, Palù G, Gribaudo G, Loregian A.
    Antiviral Res; 2019 Apr 08; 164():52-60. PubMed ID: 30738836
    [Abstract] [Full Text] [Related]

  • 20. Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein.
    Defechereux P, Debrus S, Baudoux L, Schoonbroodt S, Merville MP, Rentier B, Piette J.
    J Gen Virol; 1996 Jul 08; 77 ( Pt 7)():1505-13. PubMed ID: 8757993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.